相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Categories, components, and techniques in a modular construction of basket trials for application and further research
Moritz Pohl et al.
BIOMETRICAL JOURNAL (2021)
Bayesian methods for the analysis of early-phase oncology basket trials with information borrowing across cancer types
Jin Jin et al.
STATISTICS IN MEDICINE (2020)
Variance prior specification for a basket trial design using Bayesian hierarchical modeling
Kristen M. Cunanan et al.
CLINICAL TRIALS (2019)
Bayesian bivariate meta-analysis of correlated effects: Impact of the prior distributions on the between-study correlation, borrowing of strength, and joint inferences
Danielle L. Burke et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2018)
New designs for basket clinical trials in oncology
Richard Simon
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2018)
A Bayesian basket trial design using a calibrated Bayesian hierarchical model
Yiyi Chu et al.
CLINICAL TRIALS (2018)
Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial
Bob T. Li et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket Study
John D. Hainsworth et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Bayesian basket trial design with exchangeability monitoring
Brian P. Hobbs et al.
STATISTICS IN MEDICINE (2018)
Bayesian hierarchical modeling based on multisource exchangeability
Alexander M. Kaizer et al.
BIOSTATISTICS (2018)
Robust exchangeability designs for early phase clinical trials with multiple strata
Beat Neuenschwander et al.
PHARMACEUTICAL STATISTICS (2016)
Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations
David M. Hyman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Borrowing Information across Subgroups in Phase II Trials: Is It Useful?
Boris Freidlin et al.
CLINICAL CANCER RESEARCH (2013)
Bayesian hierarchical modeling of patient subpopulations: Efficient designs of Phase II oncology clinical trials
Scott M. Berry et al.
CLINICAL TRIALS (2013)
Phase II, open-label study evaluating the activity of imatinib in treating life-threatening malignancies known to be associated with imatinib-sensitive tyrosine kinases
Michael C. Heinrich et al.
CLINICAL CANCER RESEARCH (2008)
How vague is vague? A simulation study of the impact of the use of vague prior distributions in MCMC using WinBUGS
PC Lambert et al.
STATISTICS IN MEDICINE (2005)
Hierarchical Bayesian approaches to phase II trials in diseases with multiple subtypes
PF Thall et al.
STATISTICS IN MEDICINE (2003)
分享论文
